Catalyst Pharmaceuticals, Inc. (CPRX) Ownership

$21.26

$0.95 (4.68%)
Last update: 04:00 PM EST
Day's range
$20.35
Day's range
$21.29

Catalyst Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/12/2025 18.90 M $410.14 M   0.51% 15.47%
VANGUARD GROUP INC 08/11/2025 8.77 M $190.22 M   3.18% 7.18%
STATE STREET CORP 08/14/2025 5.48 M $118.88 M   -0.94% 4.48%
RENAISSANCE TECHNOLOGIES LLC 08/13/2025 3.25 M $70.56 M   9.99% 2.66%
MORGAN STANLEY 08/15/2025 3.18 M $69.08 M   32.95% 2.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 08/14/2025 2.88 M $62.48 M   -15.86% 2.36%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 2.87 M $62.21 M   3.66% 2.35%
FUNDSMITH LLP 08/14/2025 2.71 M $58.79 M   25.93% 2.22%
GOLDMAN SACHS GROUP INC 08/14/2025 2.41 M $52.33 M   -23.08% 1.97%
BANK OF AMERICA CORP /DE/ 08/14/2025 2.37 M $51.34 M   30.59% 1.94%
DIMENSIONAL FUND ADVISORS LP 08/12/2025 1.91 M $41.39 M   -12.80% 1.56%
AMERICAN CENTURY COMPANIES INC 08/12/2025 1.76 M $38.15 M   233.86% 1.44%
ROYCE & ASSOCIATES LP 08/11/2025 1.58 M $34.35 M   -0.97% 1.30%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 1.44 M $31.16 M   8.24% 1.18%
BOSTON PARTNERS 08/12/2025 1.28 M $27.93 M   0.58% 1.05%
NORTHERN TRUST CORP 08/13/2025 1.28 M $27.67 M   -14.20% 1.04%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2025 1.22 M $26.55 M   18.22% 1.00%
INVESCO LTD. 08/13/2025 1.21 M $26.34 M   1.17% 0.99%
ALLIANZ ASSET MANAGEMENT GMBH 07/28/2025 1.04 M $22.52 M   49.51% 0.85%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2025 1.01 M $22.01 M   33.42% 0.83%
KENNEDY CAPITAL MANAGEMENT LLC 08/13/2025 1.01 M $21.91 M   -4.89% 0.83%
NUVEEN, LLC 08/12/2025 986.27 K $21.40 M   28.42% 0.81%
MACQUARIE GROUP LTD 08/14/2025 905.29 K $19.65 M   -3.14% 0.74%
RAYMOND JAMES FINANCIAL INC 08/14/2025 845.05 K $18.34 M   91.83% 0.69%
UBS GROUP AG 08/14/2025 844.78 K $18.33 M   11.24% 0.69%
JANUS HENDERSON GROUP PLC 08/14/2025 751.56 K $16.31 M   134.99% 0.62%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2025 735.70 K $15.97 M   -24.75% 0.60%
BANK OF NEW YORK MELLON CORP 08/05/2025 719.75 K $15.62 M   1.38% 0.59%
ABRDN PLC 07/24/2025 688.76 K $14.95 M   -10.00% 0.56%
LEGAL & GENERAL GROUP PLC 08/12/2025 663.60 K $14.40 M   15.68% 0.54%
PACER ADVISORS, INC. 08/12/2025 645.13 K $14.00 M   -24.49% 0.53%
PRINCIPAL FINANCIAL GROUP INC 08/08/2025 623.97 K $13.54 M   1.05% 0.51%
SWEDBANK AB 07/10/2025 616.13 K $13.37 M   0.00% 0.50%
UBS ASSET MANAGEMENT AMERICAS INC 08/14/2025 585.67 K $12.71 M   11.28% 0.48%
METLIFE INVESTMENT MANAGEMENT, LLC 08/13/2025 582.72 K $12.65 M   -19.52% 0.48%
LSV ASSET MANAGEMENT 08/11/2025 577.70 K $12.54 M   -17.92% 0.47%
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 08/13/2025 552.70 K $11.99 M   -29.76% 0.45%
JUPITER ASSET MANAGEMENT LTD 08/08/2025 517.67 K $11.23 M   5.95% 0.42%
FMR LLC 08/14/2025 509.11 K $11.05 M   59.16% 0.42%
OBERWEIS ASSET MANAGEMENT INC/ 08/14/2025 468.20 K $10.16 M   0.13% 0.38%
PUBLIC SECTOR PENSION INVESTMENT BOARD 08/12/2025 466.40 K $10.12 M   13.55% 0.38%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2025 457.84 K $9.94 M   -9.60% 0.37%
JPMORGAN CHASE & CO 08/12/2025 433.72 K $9.41 M   23.03% 0.36%
MAN GROUP PLC 08/14/2025 430.90 K $9.35 M   45.70% 0.35%
MILLENNIUM MANAGEMENT LLC 08/14/2025 430.13 K $9.33 M   41.71% 0.35%
ORBIMED ADVISORS LLC 08/14/2025 416.90 K $9.05 M   100.00% 0.34%
GABLES CAPITAL MANAGEMENT INC. 07/30/2025 409.02 K $8.88 M   -1.77% 0.33%
AQR CAPITAL MANAGEMENT LLC 08/14/2025 398.42 K $8.65 M   -10.57% 0.33%
CLARK CAPITAL MANAGEMENT GROUP, INC. 08/14/2025 392.37 K $8.51 M   60.15% 0.32%
JW ASSET MANAGEMENT, LLC 08/11/2025 388.39 K $8.43 M   -6.05% 0.32%

Catalyst Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 452 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals, Inc.. The most heavily invested institutionals were:

Dakota Community Bank & Trust NA: 0

Redhawk Wealth Advisors, Inc.: 0

Inspire Investing, LLC: 0

BlackRock, Inc.: 18.9 M

VANGUARD GROUP INC: 8.77 M

STATE STREET CORP: 5.48 M

82.99% of Catalyst Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 123.47 M shares in the last 24 months. This purchase volume represents approximately $2.63 B in transactions.